Clinical Trial Update: Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a nutritional supplement containing arginine, omega-3 fatty acids, and nucleotides in patients with Stage III/IV head and neck…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement (Arginine / omega-3 fatty acids / nucleotides nutritional supplement)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED